Skip to NavigationSkip to content

falsified medicines

Top Ten most popular articles on Pharmafile.com this week!

News that the FDA’s advisory panel had recommended Janssen’s intranasal esketamine spray Spravato as a treatment for treatment resistant depression, took the top spot this week. The therapy, based on party drug ketamine, may act as a significant breakthrough in the neglected area of mental health.

Other news saw England’s chief medical officer Dame Sally Davies, who is leaving her current role to become Master of trinity College Cambridge, suggest that as many as one third of antibiotics may be prescribed inappropriately.

Top Ten most popular articles on Pharmafile.com this week!

The strike in Ireland featured twice in this week’s top 10 after Pfizer employees in County Cork lost a dispute over pensions. Two of our features also appeared in the top stories of the week. While ‘Counterfeit drugs – countering the lies’, picks apart ‘common sense’ claims on counterfeit drugs in asking to what extent the problem of falsified medicines is a problem at all; ‘Repurposed drugs’ looks at the Supreme Court ruling on the Lyrica patent and asks what it means.

FMD would not apply in case of no-deal Brexit

The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British Pharmaceutical Industry (ABPI) has warned. The scrapping of the EU legislation could put patients at risk.

Counterfeit drugs – countering the lies

Published on 04/02/19 at 11:38am

As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit drugs

If you were to read the news, you might be led to believe that ‘counterfeit medicines’ should be of major concern. The image painted is one in which sophisticated criminal networks introduce a constant stream of huge quantities of ‘fake drugs’ into the legitimate pharmaceutical supply chain, without concern for the many lives that they harm.

DIA Middle East CMC Conference

Study reveals true scale of falsified medicines problem

The full scope and prevalence of counterfeit medicines is poorly understood, according to a study of global pharma supply chains.

The research from a team at the University of California San Diego, the only study of its kind with global statistics on counterfeit medicines, uncovered the ‘surprise’ finding that “little is known about the precise scope of the problem and how few mechanisms exist to monitor it”.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches